Nucleocapsid-specific antibodies as a correlate of protection against SARS-CoV-2 reinfection in children - 05/08/23
Doi : 10.1016/j.jinf.2023.06.018
Alexander C. Dowell
Institute of Immunology & Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom
Dagmar Waiblinger, John Wright 1
Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, United Kingdom
Shamez N. Ladhani 2
Immunisation Department, UK Health Security Agency, 61 Colindale Avenue, London, United Kingdom
Paul Moss ⁎, 3 
for the sKIDS Investigation team
Institute of Immunology & Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom
∗Corresponding author.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Le texte complet de cet article est disponible en PDF.
© 2023
The British Infection Association. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 87 - N° 3
P. 267-269 - septembre 2023 Retour au numéro
Article précédent
- Genomic characteristics of SARS-CoV-2 variants and their clinical impact on patients with COVID-19 in Taiwan
- Hung-Chieh Su, Zi-Lun Lai, Yu-Chang Chang, Meng-Yu Cheng, Wen-Hsin Hsih, Yi-Jhen Chen, Chia-Huei Chou, Chieh-Lung Chen, Yu-Chao Lin, Tsai-Hsiu Lin, Chiung-Tzu Hsiao, Mao-Wang Ho, Hong-Mo Shih, Po-Ren Hsueh, Der-Yang Cho
- Neutralizing antibodies response to novel SARS-CoV-2 omicron sublineages in long-term care facility residents after the fourth dose of monovalent BNT162b2 COVID-19 vaccination
- Ilenia Varasi, Alessia Lai, Lia Fiaschi, Annalisa Bergna, Antonella Gatti, Barbara Caimi, Camilla Biba, Carla Della Ventura, Claudia Balotta, Agostino Riva, Gianguglielmo Zehender, Maurizio Zazzi, Ilaria Vicenti
Bienvenue sur EM-consulte, la référence des professionnels de santé.